血管内皮増殖因子Bの世界市場（～2026年）

• 英文タイトル：Global Vascular Endothelial Growth Factor B Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY12961
• 出版社/出版日：QYResearch / 2020年11月30日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、117ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は血管内皮増殖因子Bのグローバル市場について調査・分析したレポートです。種類別（アフリベルセプト、アフリベルセプトバイオシミラー、CSL-346、その他）市場規模、用途別（直腸がん、網膜静脈閉塞症、糖尿病性腎症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別血管内皮増殖因子Bの競争状況、市場シェア
・世界の血管内皮増殖因子B市場：種類別市場規模 2015年-2020年（アフリベルセプト、アフリベルセプトバイオシミラー、CSL-346、その他）
・世界の血管内皮増殖因子B市場：種類別市場規模予測 2021年-2026年（アフリベルセプト、アフリベルセプトバイオシミラー、CSL-346、その他）
・世界の血管内皮増殖因子B市場：用途別市場規模 2015年-2020年（直腸がん、網膜静脈閉塞症、糖尿病性腎症、その他）
・世界の血管内皮増殖因子B市場：用途別市場規模予測 2021年-2026年（直腸がん、網膜静脈閉塞症、糖尿病性腎症、その他）
・北米の血管内皮増殖因子B市場分析：米国、カナダ
・ヨーロッパの血管内皮増殖因子B市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの血管内皮増殖因子B市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の血管内皮増殖因子B市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの血管内皮増殖因子B市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Alteogen Inc、CSL Ltd、Eli Lilly and Company、Formycon AG、Regeneron Pharmaceuticals Inc
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Vascular Endothelial Growth Factor B Market
The global Vascular Endothelial Growth Factor B market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Vascular Endothelial Growth Factor B Scope and Market Size
Vascular Endothelial Growth Factor B market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vascular Endothelial Growth Factor B market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Vascular Endothelial Growth Factor B market is segmented into
Aflibercept
Aflibercept Biosimilar
CSL-346
Others

Segment by Application, the Vascular Endothelial Growth Factor B market is segmented into
Rectal Cancer
Retinal Vein Occlusion
Diabetic Nephropathy
Others

Regional and Country-level Analysis
The Vascular Endothelial Growth Factor B market is analysed and market size information is provided by regions (countries).
The key regions covered in the Vascular Endothelial Growth Factor B market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Vascular Endothelial Growth Factor B Market Share Analysis
Vascular Endothelial Growth Factor B market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vascular Endothelial Growth Factor B business, the date to enter into the Vascular Endothelial Growth Factor B market, Vascular Endothelial Growth Factor B product introduction, recent developments, etc.

The major vendors covered:
Alteogen Inc
CSL Ltd
Eli Lilly and Company
Formycon AG
Regeneron Pharmaceuticals Inc
…

レポート目次

1 Study Coverage
1.1 Vascular Endothelial Growth Factor B Product Introduction
1.2 Market Segments
1.3 Key Vascular Endothelial Growth Factor B Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Type
1.4.2 Aflibercept
1.4.3 Aflibercept Biosimilar
1.4.4 CSL-346
1.4.5 Others
1.5 Market by Application
1.5.1 Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Application
1.5.2 Rectal Cancer
1.5.3 Retinal Vein Occlusion
1.5.4 Diabetic Nephropathy
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Vascular Endothelial Growth Factor B Market Size, Estimates and Forecasts
2.1.1 Global Vascular Endothelial Growth Factor B Revenue 2015-2026
2.1.2 Global Vascular Endothelial Growth Factor B Sales 2015-2026
2.2 Global Vascular Endothelial Growth Factor B, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Vascular Endothelial Growth Factor B Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Vascular Endothelial Growth Factor B Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Vascular Endothelial Growth Factor B Competitor Landscape by Players
3.1 Vascular Endothelial Growth Factor B Sales by Manufacturers
3.1.1 Vascular Endothelial Growth Factor B Sales by Manufacturers (2015-2020)
3.1.2 Vascular Endothelial Growth Factor B Sales Market Share by Manufacturers (2015-2020)
3.2 Vascular Endothelial Growth Factor B Revenue by Manufacturers
3.2.1 Vascular Endothelial Growth Factor B Revenue by Manufacturers (2015-2020)
3.2.2 Vascular Endothelial Growth Factor B Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Vascular Endothelial Growth Factor B Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Vascular Endothelial Growth Factor B Revenue in 2019
3.2.5 Global Vascular Endothelial Growth Factor B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Vascular Endothelial Growth Factor B Price by Manufacturers
3.4 Vascular Endothelial Growth Factor B Manufacturing Base Distribution, Product Types
3.4.1 Vascular Endothelial Growth Factor B Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vascular Endothelial Growth Factor B Product Type
3.4.3 Date of International Manufacturers Enter into Vascular Endothelial Growth Factor B Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Vascular Endothelial Growth Factor B Market Size by Type (2015-2020)
4.1.1 Global Vascular Endothelial Growth Factor B Sales by Type (2015-2020)
4.1.2 Global Vascular Endothelial Growth Factor B Revenue by Type (2015-2020)
4.1.3 Vascular Endothelial Growth Factor B Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Vascular Endothelial Growth Factor B Market Size Forecast by Type (2021-2026)
4.2.1 Global Vascular Endothelial Growth Factor B Sales Forecast by Type (2021-2026)
4.2.2 Global Vascular Endothelial Growth Factor B Revenue Forecast by Type (2021-2026)
4.2.3 Vascular Endothelial Growth Factor B Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Vascular Endothelial Growth Factor B Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Vascular Endothelial Growth Factor B Market Size by Application (2015-2020)
5.1.1 Global Vascular Endothelial Growth Factor B Sales by Application (2015-2020)
5.1.2 Global Vascular Endothelial Growth Factor B Revenue by Application (2015-2020)
5.1.3 Vascular Endothelial Growth Factor B Price by Application (2015-2020)
5.2 Vascular Endothelial Growth Factor B Market Size Forecast by Application (2021-2026)
5.2.1 Global Vascular Endothelial Growth Factor B Sales Forecast by Application (2021-2026)
5.2.2 Global Vascular Endothelial Growth Factor B Revenue Forecast by Application (2021-2026)
5.2.3 Global Vascular Endothelial Growth Factor B Price Forecast by Application (2021-2026)

6 North America
6.1 North America Vascular Endothelial Growth Factor B by Country
6.1.1 North America Vascular Endothelial Growth Factor B Sales by Country
6.1.2 North America Vascular Endothelial Growth Factor B Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Vascular Endothelial Growth Factor B Market Facts & Figures by Type
6.3 North America Vascular Endothelial Growth Factor B Market Facts & Figures by Application

7 Europe
7.1 Europe Vascular Endothelial Growth Factor B by Country
7.1.1 Europe Vascular Endothelial Growth Factor B Sales by Country
7.1.2 Europe Vascular Endothelial Growth Factor B Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vascular Endothelial Growth Factor B Market Facts & Figures by Type
7.3 Europe Vascular Endothelial Growth Factor B Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Vascular Endothelial Growth Factor B by Region
8.1.1 Asia Pacific Vascular Endothelial Growth Factor B Sales by Region
8.1.2 Asia Pacific Vascular Endothelial Growth Factor B Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Vascular Endothelial Growth Factor B Market Facts & Figures by Type
8.3 Asia Pacific Vascular Endothelial Growth Factor B Market Facts & Figures by Application

9 Latin America
9.1 Latin America Vascular Endothelial Growth Factor B by Country
9.1.1 Latin America Vascular Endothelial Growth Factor B Sales by Country
9.1.2 Latin America Vascular Endothelial Growth Factor B Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Vascular Endothelial Growth Factor B Market Facts & Figures by Type
9.3 Central & South America Vascular Endothelial Growth Factor B Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Vascular Endothelial Growth Factor B by Country
10.1.1 Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country
10.1.2 Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Vascular Endothelial Growth Factor B Market Facts & Figures by Type
10.3 Middle East and Africa Vascular Endothelial Growth Factor B Market Facts & Figures by Application

11 Company Profiles
11.1 Alteogen Inc
11.1.1 Alteogen Inc Corporation Information
11.1.2 Alteogen Inc Description and Business Overview
11.1.3 Alteogen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alteogen Inc Vascular Endothelial Growth Factor B Products Offered
11.1.5 Alteogen Inc Related Developments
11.2 CSL Ltd
11.2.1 CSL Ltd Corporation Information
11.2.2 CSL Ltd Description and Business Overview
11.2.3 CSL Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL Ltd Vascular Endothelial Growth Factor B Products Offered
11.2.5 CSL Ltd Related Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Corporation Information
11.3.2 Eli Lilly and Company Description and Business Overview
11.3.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Products Offered
11.3.5 Eli Lilly and Company Related Developments
11.4 Formycon AG
11.4.1 Formycon AG Corporation Information
11.4.2 Formycon AG Description and Business Overview
11.4.3 Formycon AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Formycon AG Vascular Endothelial Growth Factor B Products Offered
11.4.5 Formycon AG Related Developments
11.5 Regeneron Pharmaceuticals Inc
11.5.1 Regeneron Pharmaceuticals Inc Corporation Information
11.5.2 Regeneron Pharmaceuticals Inc Description and Business Overview
11.5.3 Regeneron Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Products Offered
11.5.5 Regeneron Pharmaceuticals Inc Related Developments
11.1 Alteogen Inc
11.1.1 Alteogen Inc Corporation Information
11.1.2 Alteogen Inc Description and Business Overview
11.1.3 Alteogen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alteogen Inc Vascular Endothelial Growth Factor B Products Offered
11.1.5 Alteogen Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Vascular Endothelial Growth Factor B Market Estimates and Projections by Region
12.1.1 Global Vascular Endothelial Growth Factor B Sales Forecast by Regions 2021-2026
12.1.2 Global Vascular Endothelial Growth Factor B Revenue Forecast by Regions 2021-2026
12.2 North America Vascular Endothelial Growth Factor B Market Size Forecast (2021-2026)
12.2.1 North America: Vascular Endothelial Growth Factor B Sales Forecast (2021-2026)
12.2.2 North America: Vascular Endothelial Growth Factor B Revenue Forecast (2021-2026)
12.2.3 North America: Vascular Endothelial Growth Factor B Market Size Forecast by Country (2021-2026)
12.3 Europe Vascular Endothelial Growth Factor B Market Size Forecast (2021-2026)
12.3.1 Europe: Vascular Endothelial Growth Factor B Sales Forecast (2021-2026)
12.3.2 Europe: Vascular Endothelial Growth Factor B Revenue Forecast (2021-2026)
12.3.3 Europe: Vascular Endothelial Growth Factor B Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Vascular Endothelial Growth Factor B Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Vascular Endothelial Growth Factor B Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Vascular Endothelial Growth Factor B Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Vascular Endothelial Growth Factor B Market Size Forecast by Region (2021-2026)
12.5 Latin America Vascular Endothelial Growth Factor B Market Size Forecast (2021-2026)
12.5.1 Latin America: Vascular Endothelial Growth Factor B Sales Forecast (2021-2026)
12.5.2 Latin America: Vascular Endothelial Growth Factor B Revenue Forecast (2021-2026)
12.5.3 Latin America: Vascular Endothelial Growth Factor B Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Vascular Endothelial Growth Factor B Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Vascular Endothelial Growth Factor B Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Vascular Endothelial Growth Factor B Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Vascular Endothelial Growth Factor B Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Vascular Endothelial Growth Factor B Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vascular Endothelial Growth Factor B Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Vascular Endothelial Growth Factor B Market Segments
Table 2. Ranking of Global Top Vascular Endothelial Growth Factor B Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Aflibercept
Table 5. Major Manufacturers of Aflibercept Biosimilar
Table 6. Major Manufacturers of CSL-346
Table 7. Major Manufacturers of Others
Table 8. Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Vascular Endothelial Growth Factor B Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Vascular Endothelial Growth Factor B Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Vascular Endothelial Growth Factor B Sales Market Share by Regions (2015-2020)
Table 12. Global Vascular Endothelial Growth Factor B Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Vascular Endothelial Growth Factor B Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Vascular Endothelial Growth Factor B Sales Share by Manufacturers (2015-2020)
Table 15. Global Vascular Endothelial Growth Factor B Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Vascular Endothelial Growth Factor B by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vascular Endothelial Growth Factor B as of 2019)
Table 17. Vascular Endothelial Growth Factor B Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Vascular Endothelial Growth Factor B Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Vascular Endothelial Growth Factor B Price (2015-2020) (USD/Pcs)
Table 20. Vascular Endothelial Growth Factor B Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Vascular Endothelial Growth Factor B Product Type
Table 22. Date of International Manufacturers Enter into Vascular Endothelial Growth Factor B Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Vascular Endothelial Growth Factor B Sales by Type (2015-2020) (K Pcs)
Table 25. Global Vascular Endothelial Growth Factor B Sales Share by Type (2015-2020)
Table 26. Global Vascular Endothelial Growth Factor B Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Vascular Endothelial Growth Factor B Revenue Share by Type (2015-2020)
Table 28. Vascular Endothelial Growth Factor B Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Vascular Endothelial Growth Factor B Sales by Application (2015-2020) (K Pcs)
Table 30. Global Vascular Endothelial Growth Factor B Sales Share by Application (2015-2020)
Table 31. North America Vascular Endothelial Growth Factor B Sales by Country (2015-2020) (K Pcs)
Table 32. North America Vascular Endothelial Growth Factor B Sales Market Share by Country (2015-2020)
Table 33. North America Vascular Endothelial Growth Factor B Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Vascular Endothelial Growth Factor B Revenue Market Share by Country (2015-2020)
Table 35. North America Vascular Endothelial Growth Factor B Sales by Type (2015-2020) (K Pcs)
Table 36. North America Vascular Endothelial Growth Factor B Sales Market Share by Type (2015-2020)
Table 37. North America Vascular Endothelial Growth Factor B Sales by Application (2015-2020) (K Pcs)
Table 38. North America Vascular Endothelial Growth Factor B Sales Market Share by Application (2015-2020)
Table 39. Europe Vascular Endothelial Growth Factor B Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country (2015-2020)
Table 41. Europe Vascular Endothelial Growth Factor B Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country (2015-2020)
Table 43. Europe Vascular Endothelial Growth Factor B Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Vascular Endothelial Growth Factor B Sales Market Share by Type (2015-2020)
Table 45. Europe Vascular Endothelial Growth Factor B Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Vascular Endothelial Growth Factor B Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Vascular Endothelial Growth Factor B Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Vascular Endothelial Growth Factor B Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Vascular Endothelial Growth Factor B Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Vascular Endothelial Growth Factor B Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Vascular Endothelial Growth Factor B Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Vascular Endothelial Growth Factor B Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Vascular Endothelial Growth Factor B Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Vascular Endothelial Growth Factor B Sales Market Share by Application (2015-2020)
Table 55. Latin America Vascular Endothelial Growth Factor B Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Vascular Endothelial Growth Factor B Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Vascular Endothelial Growth Factor B Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Vascular Endothelial Growth Factor B Revenue Market Share by Country (2015-2020)
Table 59. Latin America Vascular Endothelial Growth Factor B Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Vascular Endothelial Growth Factor B Sales Market Share by Type (2015-2020)
Table 61. Latin America Vascular Endothelial Growth Factor B Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Vascular Endothelial Growth Factor B Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Vascular Endothelial Growth Factor B Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Application (2015-2020)
Table 71. Alteogen Inc Corporation Information
Table 72. Alteogen Inc Description and Major Businesses
Table 73. Alteogen Inc Vascular Endothelial Growth Factor B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Alteogen Inc Product
Table 75. Alteogen Inc Recent Development
Table 76. CSL Ltd Corporation Information
Table 77. CSL Ltd Description and Major Businesses
Table 78. CSL Ltd Vascular Endothelial Growth Factor B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. CSL Ltd Product
Table 80. CSL Ltd Recent Development
Table 81. Eli Lilly and Company Corporation Information
Table 82. Eli Lilly and Company Description and Major Businesses
Table 83. Eli Lilly and Company Vascular Endothelial Growth Factor B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Eli Lilly and Company Product
Table 85. Eli Lilly and Company Recent Development
Table 86. Formycon AG Corporation Information
Table 87. Formycon AG Description and Major Businesses
Table 88. Formycon AG Vascular Endothelial Growth Factor B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Formycon AG Product
Table 90. Formycon AG Recent Development
Table 91. Regeneron Pharmaceuticals Inc Corporation Information
Table 92. Regeneron Pharmaceuticals Inc Description and Major Businesses
Table 93. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Regeneron Pharmaceuticals Inc Product
Table 95. Regeneron Pharmaceuticals Inc Recent Development
Table 96. Global Vascular Endothelial Growth Factor B Sales Forecast by Regions (2021-2026) (K Pcs)
Table 97. Global Vascular Endothelial Growth Factor B Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global Vascular Endothelial Growth Factor B Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global Vascular Endothelial Growth Factor B Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: Vascular Endothelial Growth Factor B Sales Forecast by Country (2021-2026) (K Pcs)
Table 101. North America: Vascular Endothelial Growth Factor B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: Vascular Endothelial Growth Factor B Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Europe: Vascular Endothelial Growth Factor B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: Vascular Endothelial Growth Factor B Sales Forecast by Region (2021-2026) (K Pcs)
Table 105. Asia Pacific: Vascular Endothelial Growth Factor B Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: Vascular Endothelial Growth Factor B Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. Latin America: Vascular Endothelial Growth Factor B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: Vascular Endothelial Growth Factor B Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Middle East and Africa: Vascular Endothelial Growth Factor B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Vascular Endothelial Growth Factor B Players
Table 114. Vascular Endothelial Growth Factor B Customers List
Table 115. Vascular Endothelial Growth Factor B Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Vascular Endothelial Growth Factor B Product Picture
Figure 2. Global Vascular Endothelial Growth Factor B Sales Market Share by Type in 2020 & 2026
Figure 3. Aflibercept Product Picture
Figure 4. Aflibercept Biosimilar Product Picture
Figure 5. CSL-346 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vascular Endothelial Growth Factor B Sales Market Share by Application in 2020 & 2026
Figure 8. Rectal Cancer
Figure 9. Retinal Vein Occlusion
Figure 10. Diabetic Nephropathy
Figure 11. Others
Figure 12. Vascular Endothelial Growth Factor B Report Years Considered
Figure 13. Global Vascular Endothelial Growth Factor B Market Size 2015-2026 (US$ Million)
Figure 14. Global Vascular Endothelial Growth Factor B Sales 2015-2026 (K Pcs)
Figure 15. Global Vascular Endothelial Growth Factor B Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Vascular Endothelial Growth Factor B Sales Market Share by Region (2015-2020)
Figure 17. Global Vascular Endothelial Growth Factor B Sales Market Share by Region in 2019
Figure 18. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region (2015-2020)
Figure 19. Global Vascular Endothelial Growth Factor B Revenue Market Share by Region in 2019
Figure 20. Global Vascular Endothelial Growth Factor B Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Vascular Endothelial Growth Factor B Revenue in 2019
Figure 22. Vascular Endothelial Growth Factor B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Vascular Endothelial Growth Factor B Sales Market Share by Type (2015-2020)
Figure 24. Global Vascular Endothelial Growth Factor B Sales Market Share by Type in 2019
Figure 25. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type (2015-2020)
Figure 26. Global Vascular Endothelial Growth Factor B Revenue Market Share by Type in 2019
Figure 27. Global Vascular Endothelial Growth Factor B Market Share by Price Range (2015-2020)
Figure 28. Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2015-2020)
Figure 29. Global Vascular Endothelial Growth Factor B Sales Market Share by Application in 2019
Figure 30. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2015-2020)
Figure 31. Global Vascular Endothelial Growth Factor B Revenue Market Share by Application in 2019
Figure 32. North America Vascular Endothelial Growth Factor B Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Vascular Endothelial Growth Factor B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Vascular Endothelial Growth Factor B Sales Market Share by Country in 2019
Figure 35. North America Vascular Endothelial Growth Factor B Revenue Market Share by Country in 2019
Figure 36. U.S. Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Vascular Endothelial Growth Factor B Market Share by Type in 2019
Figure 41. North America Vascular Endothelial Growth Factor B Market Share by Application in 2019
Figure 42. Europe Vascular Endothelial Growth Factor B Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Vascular Endothelial Growth Factor B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Vascular Endothelial Growth Factor B Sales Market Share by Country in 2019
Figure 45. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Country in 2019
Figure 46. Germany Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Vascular Endothelial Growth Factor B Market Share by Type in 2019
Figure 57. Europe Vascular Endothelial Growth Factor B Market Share by Application in 2019
Figure 58. Asia Pacific Vascular Endothelial Growth Factor B Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Vascular Endothelial Growth Factor B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Vascular Endothelial Growth Factor B Sales Market Share by Region in 2019
Figure 61. Asia Pacific Vascular Endothelial Growth Factor B Revenue Market Share by Region in 2019
Figure 62. China Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Vascular Endothelial Growth Factor B Market Share by Type in 2019
Figure 85. Asia Pacific Vascular Endothelial Growth Factor B Market Share by Application in 2019
Figure 86. Latin America Vascular Endothelial Growth Factor B Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Vascular Endothelial Growth Factor B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Vascular Endothelial Growth Factor B Sales Market Share by Country in 2019
Figure 89. Latin America Vascular Endothelial Growth Factor B Revenue Market Share by Country in 2019
Figure 90. Mexico Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Vascular Endothelial Growth Factor B Market Share by Type in 2019
Figure 97. Latin America Vascular Endothelial Growth Factor B Market Share by Application in 2019
Figure 98. Middle East and Africa Vascular Endothelial Growth Factor B Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Market Share by Country in 2019
Figure 102. Turkey Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Vascular Endothelial Growth Factor B Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Vascular Endothelial Growth Factor B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Vascular Endothelial Growth Factor B Market Share by Type in 2019
Figure 109. Middle East and Africa Vascular Endothelial Growth Factor B Market Share by Application in 2019
Figure 110. North America Vascular Endothelial Growth Factor B Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Vascular Endothelial Growth Factor B Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Vascular Endothelial Growth Factor B Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Vascular Endothelial Growth Factor B Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Vascular Endothelial Growth Factor B Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Vascular Endothelial Growth Factor B Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Vascular Endothelial Growth Factor B Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Vascular Endothelial Growth Factor B Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Vascular Endothelial Growth Factor B Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

以下、関連資料のご紹介

血管内皮増殖因子阻害薬の世界市場（～2026年）

Global Vascular Endothelial Growth Factor Inhibitor Market Insights and Forecast to 2026
MRC2-11QY12962 2020年11月30日 116Pages
当調査資料は血管内皮増殖因子阻害薬のグローバル市場について調査・分析したレポートです。種類別（経口薬、注射）市場規模、用途別（病院、外来手術センター、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

血管プロテーゼの世界市場（～2026年）

Global Vascular Prostheses Market Size, Status and Forecast 2020-2026
MRC2-11QY04980 2020年11月20日 125Pages
当調査資料は血管プロテーゼのグローバル市場について調査・分析したレポートです。種類別（合成プロテーゼ（ePTFEまたはポリエステル）、生物学的プロテーゼ、生合成プロテーゼ）市場規模、用途別（動脈、静脈）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、ア...

間質血管画分の世界市場（～2026年）

Global Stromal Vascular Fraction Market Size, Status and Forecast 2020-2026
MRC2-11QY04746 2020年11月20日 92Pages
当調査資料は間質血管画分のグローバル市場について調査・分析したレポートです。種類別（SVF分離製品、酵素分離、非酵素分離、自動POCデバイス、SVF吸引精製製品、SVFトランスファー製品）市場規模、用途別（病院、専門クリニック、幹細胞バンク/研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨー...

第IX因子欠乏症治療の世界市場（～2026年）

Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11918 2020年11月25日 96Pages
当調査資料は第IX因子欠乏症治療のグローバル市場について調査・分析したレポートです。種類別（血友病B、血友病B阻害剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

インテグリンベータ3の世界市場（～2026年）

Global Integrin Beta 3 Market Insights and Forecast to 2026
MRC2-11QY01761 2020年11月20日 110Pages
当調査資料はインテグリンベータ3のグローバル市場について調査・分析したレポートです。種類別（MSP-68、OCU-200、AC-301、C-16Y、その他）市場規模、用途別（黒色腫、動脈血栓症、糖尿病性黄斑浮腫、肺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

末梢血管診断システムの世界市場（～2026年）

Global Peripheral Vascular Diagnostic Systems Market Size, Status and Forecast 2020-2026
MRC2-11QY04223 2020年11月20日 95Pages
当調査資料は末梢血管診断システムのグローバル市場について調査・分析したレポートです。種類別（糖尿病、クリティカルリム虚血）市場規模、用途別（ASC、病院、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

血友病A・B組換え因子補充療法の世界市場（～2026年）

Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size, Status and Forecast 2020-2026
MRC2-11QY12158 2020年11月25日 94Pages
当調査資料は血友病A・B組換え因子補充療法のグローバル市場について調査・分析したレポートです。種類別（血友病A、血友病B）市場規模、用途別（病院、クリニック、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

線維芽細胞成長因子2の世界市場（～2026年）

Global Fibroblast Growth Factor 2 Market Insights and Forecast to 2026
MRC2-11QY06112 2020年11月20日 118Pages
当調査資料は線維芽細胞成長因子2のグローバル市場について調査・分析したレポートです。種類別（CT-400P、DVC-10101、NK-4、RBM-007、その他）市場規模、用途別（軟骨無形成症、骨障害、がん性疼痛、膵臓がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、...

インテグリンアルファVの世界市場（～2026年）

Global Integrin Alpha V Market Insights and Forecast to 2026
MRC2-11QY01759 2020年11月20日 112Pages
当調査資料はインテグリンアルファVのグローバル市場について調査・分析したレポートです。種類別（MK-0429、C-16Y、264-RAD、AC-301、その他）市場規模、用途別（代謝性疾患、眼科、呼吸器、感染症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イ...

グリア細胞株由来神経栄養因子の世界市場（～2026年）

Global Glial Cell Line Derived Neurotrophic Factor Market Insights and Forecast to 2026
MRC2-11QY06841 2020年11月20日 119Pages
当調査資料はグリア細胞株由来神経栄養因子のグローバル市場について調査・分析したレポートです。種類別（GSK-812、LAUR-301、TW-002、AMT-090、その他）市場規模、用途別（筋萎縮性側索硬化症、脳虚血、パーキンソン病、網膜変性、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ...

血管内皮増殖因子阻害薬の世界市場（～2026年） Market Analysis and Insights: Global Vascular Endothelial Growth Factor Inhibitor Market The global Vascular Endothelial Growth Factor Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vascular Endothelial Grow…
胎盤成長因子の世界市場（～2026年） Market Analysis and Insights: Global Placenta Growth Factor Market The global Placenta Growth Factor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Placenta Growth Factor Scope and Market Size Placenta Growth Factor m…
血管プロテーゼの世界市場（～2026年） Market Analysis and Insights: Global Vascular Prostheses Market The global Vascular Prostheses market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vascular Prostheses Scope and Market Size Vascular Prostheses market is seg…
間質血管画分の世界市場（～2026年） Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient’s own body. With increasing age, regenerative and repair properties of skin are less effective due to decrease in stem cell count, …
インテグリンベータ3の世界市場（～2026年） Market Analysis and Insights: Global Integrin Beta 3 Market The global Integrin Beta 3 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Integrin Beta 3 Scope and Market Size Integrin Beta 3 market is segmented by Type, …